Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Celdara Medical LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11253
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celdara Medical LLC (Celdara Medical) is a biotechnology company that helps transform academic innovations into medicines to cure serious diseases. It provides pipeline development services, and has a pipeline of anti-inflammatory therapeutics, latent HIV elimination, idiopathic pulmonary fibrosis treatments and scleroderma diagnostics. Celdara Medical collaborates with inventors and research institutions for advancing pipeline research and development, and provides the developmental, financial, and business insightfulness to advance their discoveries. The company operates a clinical diagnostic lab and a wet lab for biotech research and development. It serves patients, biotechnology and pharmaceutical leaders, innovators, and research institutions. The company has operations, partnering and funding opportunities in Greater Boston, New York City, and Washington, DC, the US. Celdara Medical is headquartered in Lebanon, New Hampshire, the US.

Celdara Medical LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celdara Medical LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Pulmatrix Enters Into Alliance with Celdara Medical 10
Asset Transactions 11
OnCyte Amends Acquisition of CAR T-Cell Portfolio from Celdara Medical 11
Acquisition 13
Cardio3 BioSciences Acquires Oncyte 13
Celdara Medical LLC – Key Competitors 15
Celdara Medical LLC – Key Employees 16
Celdara Medical LLC – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Nov 05, 2018: Celdara Medical and New York Blood Center receive SBIR contract for autoimmune discovery research 18
Nov 29, 2017: Celdara Medical and Geisel School of Medicine name SYNERGY fellowship winners 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Celdara Medical LLC, Pharmaceuticals & Healthcare, Key Facts 2
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celdara Medical LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celdara Medical LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pulmatrix Enters Into Alliance with Celdara Medical 10
OnCyte Amends Acquisition of CAR T-Cell Portfolio from Celdara Medical 11
Cardio3 BioSciences Acquires Oncyte 13
Celdara Medical LLC, Key Competitors 15
Celdara Medical LLC, Key Employees 16

List of Figures
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celdara Medical LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • S&T Bancorp Inc:企業の戦略・SWOT・財務情報
    S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. …
  • Planung Transport Verkehr AG:企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Softchoice Corporation:企業の戦略的SWOT分析
    Softchoice Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Thermalin Diabetes LLC-製薬・医療分野:企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • Atlas Iron Ltd:企業の戦略・SWOT・財務情報
    Atlas Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Atlas Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務情報
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tan Chong Motor Holdings Berhad (TCHONG):企業の財務・戦略的SWOT分析
    Tan Chong Motor Holdings Berhad (TCHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Acuity Brands Inc (AYI):企業の財務・戦略的SWOT分析
    Acuity Brands Inc (AYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • Shilpa Medicare Ltd (SHILPAMED):製薬・医療:M&Aディール及び事業提携情報
    Summary Shilpa Medicare Ltd (Shilpa Medicare) focuses on the development, manufacture and commercialization of generic pharmaceutical products and active pharmaceutical ingredients (APIs). It offers medicines for the treatment of cancer, infectious diseases such as HIV, multiple sclerosis and immuno …
  • Cabela’S Inc
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Federal Signal Corp (FSS):企業の財務・戦略的SWOT分析
    Federal Signal Corp (FSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aquion Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Aquion Energy Inc (Aquion) is a diversified company. The company manufactures and markets saltwater batteries. It offers bulk energy storage modules, M-line battery modules, and S-line battery stacks. Aquion utilizes Aqueous Hybrid Ion battery technology to provide long-duration energy stora …
  • DEKRA e.V.:企業の戦略的SWOT分析
    DEKRA e.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • State Corporation Bank for Development and Foreign Economic Affairs:電力:M&Aディール及び事業提携情報
    Summary State Corporation Bank for Development and Foreign Economic Affairs (Vnesheconombank) is a bank that offers investment banking and funding services. The company funds and supports investment projects and industrial exports through credits, guarantees and sureties, economic entities authorize …
  • Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆